InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Mirum Pharmaceuticals, Inc.

MIRM Clue Score61
United States Fiscal year ends December CIK 0001759425 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

28
Insider
Date
Role
Action
Shares
Price
Amount
Christopher Peetz
4 Nov 2026
Chief Executive Officer
Sold after exercise
20,000
$90.00
$1.80M
Christopher Peetz
1 Sep 2026
Chief Executive Officer
Sold after exercise
21,688
$98.91
$2.15M
Christopher Peetz
1 Sep 2026
Chief Executive Officer
Sold after exercise
8,312
$98.08
$815.24K
Jolanda Howe
18 Aug 2026
SVP, Global Controller
Sold after exercise
40,000
$100.00
$4.00M
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
2,300
$100.14
$230.32K
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
6,017
$99.25
$597.19K
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
11,683
$98.51
$1.15M
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
1,710
$124.79
$213.39K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
1,975
$123.74
$244.39K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
4,181
$122.34
$511.50K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
12,134
$121.65
$1.48M
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
883
$99.66
$88.00K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
1,021
$98.20
$100.26K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
1,973
$97.56
$192.49K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
6,926
$96.15
$665.93K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
16,595
$95.34
$1.58M
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
2,602
$94.64
$246.25K
Saira Ramasastry
15 May 2026
Director
Sold after exercise
2,000
$109.47
$218.94K
Saira Ramasastry
15 Apr 2026
Director
Sold after exercise
2,000
$96.90
$193.80K
Saira Ramasastry
16 Mar 2026
Director
Sold after exercise
2,000
$90.76
$181.52K
Saira Ramasastry
13 Feb 2026
Director
Sold after exercise
2,000
$102.09
$204.18K
Saira Ramasastry
15 Jan 2026
Director
Sold after exercise
2,000
$90.99
$181.98K
Saira Ramasastry
22 Dec 2025
Director
Sold after exercise
5,000
$80.00
$400.00K
Michael G Grey
19 Dec 2025
Director
Sold after exercise
50,000
$78.00
$3.90M
Saira Ramasastry
18 Dec 2025
Director
Sold after exercise
1,000
$70.00
$70.00K
Saira Ramasastry
18 Dec 2025
Director
Sold after exercise
1,000
$69.46
$69.46K
Michael G Grey
1 Dec 2025
Director
Sold after exercise
50,000
$74.00
$3.70M
Michael G Grey
21 Nov 2025
Director
Sold after exercise
50,000
$70.00
$3.50M
Show all 68 transactions →

What was left out

Form 4 filings counted 67
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 28
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 816,731
History held since 18 Jul 2019